Neoadjuvant pembrolizumab in stage IV ovarian cancer: The phase II Neo-Pembro trial

被引：0

作者：

Aronson, L. ^{[1
]}

Thijssen, B. ^{[2
]}

Lopez-Yurda, M. ^{[3
]}

Koole, S. ^{[1
]}

van der Leest, P. ^{[4
]}

Leon-Castillo, A. ^{[5
]}

Harkes, R. ^{[5
]}

Seignette, I. ^{[5
]}

Sanders, J. ^{[5
]}

Alkemade, M. ^{[6
]}

Kemper, I. ^{[7
]}

Holtkamp, M. ^{[7
]}

Mandjes, I. ^{[3
]}

Broeks, A. ^{[6
]}

Lahaye, M. ^{[8
]}

Rijlaarsdam, M. ^{[7
]}

Van Den Broek, D. ^{[4
]}

Horlings, H. M. ^{[5
]}

van Driel, W. ^{[1
]}

Sonke, G. S. ^{[7
]}

机构：

[1] Netherlands Canc Inst, Dept Gynecol Oncol, Ctr Gynecol Oncol Amsterdam, Amsterdam, Netherlands

[2] Netherlands Canc Inst, Oncode Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands

[3] Netherlands Canc Inst, Dept Biometr, Amsterdam, Netherlands

[4] Netherlands Canc Inst, Dept Lab Med, Amsterdam, Netherlands

[5] Netherlands Canc Inst, Dept Pathol, Amsterdam, Netherlands

[6] Netherlands Canc Inst, Core Facil Mol Pathol & Biobanking, Amsterdam, Netherlands

[7] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands

[8] Netherlands Canc Inst, Dept Radiol, Amsterdam, Netherlands

来源：

关键词：

D O I：

10.1016/j.annonc.2024.08.831

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

770P

引用

页码：S581 / S581

页数：1